REQUEST A DEMO
Total
USD $0.00
Search more companies

Hanmi Pharm. Co.,Ltd. (South Korea)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Hanmi Pharm. Co.,Ltd. Profile Updated: July 04, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Hanmi Pharm. Co., Ltd. engages pharmaceutical business, marketing and developing new IMD & FDC (Incrementally Modified Drug and Fixed Dose Combination) including innovative small molecules and biologics. The Company provides prescription drugs, including antidepressants, obesity drugs, oral care drugs, schizophrenia drugs, diabetes drugs, hepatitis drugs, antibiotics, osteoarthritis drugs, anti-inflammatory drugs, nootropics, epilepsy drugs, smoking cessation aid drugs, anti-cancer drugs, cardiovascular drugs, hypnotics and others. Hanmi also provides over-the-counter (OTC) drugs.

Headquarters
893-5 Hajeo-Ri, Paltan-Myeon, Hwaseong City
Hwaseong; Gyeonggi; Postal Code: 445-958

Contact Details: Purchase the Hanmi Pharm. Co.,Ltd. report to view the information.

Basic Information
Total Employees:
Purchase the Hanmi Pharm. Co.,Ltd. report to view the information.
Outstanding Shares:
Purchase the Hanmi Pharm. Co.,Ltd. report to view the information.
Registered Capital:
Purchase the Hanmi Pharm. Co.,Ltd. report to view the information.
Financial Auditors:
Purchase the Hanmi Pharm. Co.,Ltd. report to view the information.
Incorporation Date:
July 05, 2010
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Vice President
Purchase this report to view the information.
Vice Chairman
Purchase this report to view the information.
Outside Director
Ownership Details
Purchase this report to view the information.
Subsidiaries
Allegro
11.64%
(주)제네웰
3.95%
아테넥스
1.99%
Company Performance
Financial values in the chart are available after Hanmi Pharm. Co.,Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
11.07%
Total operating revenue
11.29%
Operating profit (EBIT)
48.7%
EBITDA
29.57%
Net Profit (Loss) for the Period
61.14%
Total assets
5.88%
Total equity
15.65%
Operating Profit Margin (ROS)
4.29%
Net Profit Margin
4.38%
Return on Equity (ROE)
2.55%
Debt to Equity Ratio
-12.7%
Quick Ratio
0.12%
Cash Ratio
-0.16%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?